Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson disease-associated cognitive impairment
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 767

Showing 26-50 of 767 citing articles:

Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson’s disease via inhibiting oxidative stress and ferroptosis
Li Mao, Junli Zhang, Lianyan Jiang, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 31
The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance
Martin J. Dahl, Shelby L. Bachman, Shubir Dutt, et al.
Nature Aging (2023) Vol. 3, Iss. 9, pp. 1128-1143
Open Access | Times Cited: 31
Electroacupuncture for motor dysfunction and constipation in patients with Parkinson's disease: a randomised controlled multi-centre trial
Kunshan Li, Shifen Xu, Ruiping Wang, et al.
EClinicalMedicine (2023) Vol. 56, pp. 101814-101814
Open Access | Times Cited: 29
The Impact of Motor-Cognitive Dual-Task Training on Physical and Cognitive Functions in Parkinson’s Disease
Yi Xiao, Tianmi Yang, Huifang Shang
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 437-437
Open Access | Times Cited: 29
Corticostriatal beta oscillation changes associated with cognitive function in Parkinson’s disease
Danika Paulo, Helen Qian, Deeptha Subramanian, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3662-3675
Open Access | Times Cited: 28
NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson's disease
Napissara Boonpraman, Sunmi Yoon, Chae Young Kim, et al.
Redox Biology (2023) Vol. 62, pp. 102698-102698
Open Access | Times Cited: 27
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson’s disease restoring striatal synaptic plasticity
Gioia Marino, Federica Campanelli, Giuseppina Natale, et al.
Science Advances (2023) Vol. 9, Iss. 28
Open Access | Times Cited: 26
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders
Fabiola De Marchi, Ivana Munitić, Lea Vidatic, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2793-2793
Open Access | Times Cited: 26
Neuroprotective Effects of Lactobacillus plantarum PS128 in a Mouse Model of Parkinson’s Disease: The Role of Gut Microbiota and MicroRNAs
Yan Zhang Lee, Shih-Hsuan Cheng, Min-Yu Chang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6794-6794
Open Access | Times Cited: 25
Engineered Selenium/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson’s Disease via Oral Gavage
Kai Xu, Peng Huang, Yixuan Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19961-19980
Open Access | Times Cited: 25
Multimorbidity increases the risk of dementia: a 15 year follow-up of the SHARE study
Nicola Veronese, Ai Koyanagi, Ligia J. Domínguez, et al.
Age and Ageing (2023) Vol. 52, Iss. 4
Open Access | Times Cited: 24
PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 23
Potential Alzheimer's disease therapeutic nano-platform: Discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles
Jaehoon Kim, Hyeji Um, Na Hee Kim, et al.
Bioactive Materials (2023) Vol. 24, pp. 497-506
Open Access | Times Cited: 22
C1q and central nervous system disorders
Wenjie Zhang, Yuan Chen, Hui Pei
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross‐Sectional Studies
Peikun He, Lin Shi, Yanyi Li, et al.
Annals of Neurology (2023) Vol. 94, Iss. 4, pp. 672-683
Closed Access | Times Cited: 22
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms
Javier Pagonabarraga, Helena Bejr‐Kasem, Saül Martínez‐Horta, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 3, pp. 135-150
Closed Access | Times Cited: 14
Blood-brain barrier disruption: a culprit of cognitive decline?
Ji Che, Yinying Sun, Yixu Deng, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes
Niels Okkels, Michel J. Grothe, John‐Paul Taylor, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2308-2324
Closed Access | Times Cited: 13
Multimorbidity, healthy lifestyle, and the risk of cognitive impairment in Chinese older adults: a longitudinal cohort study
Xiaolong Xing, Xueli Yang, Jinqian Chen, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke
Yang Liu, Lauren Guttman, Valina L. Dawson, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116174-116174
Closed Access | Times Cited: 12
Discovery of potent inhibitors of α-synuclein aggregation using structure-based iterative learning
Robert I. Horne, Ewa A. Andrzejewska, Parvez Alam, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 5, pp. 634-645
Open Access | Times Cited: 12
Advances in fluorescent probe development for bioimaging of potential Parkinson's biomarkers
Xiaoqian Sun, Qingqing Jiang, Yu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116195-116195
Closed Access | Times Cited: 11
Single nanozyme-based colorimetric biosensor for dopamine with enhanced selectivity via reactivity of oxidation intermediates
Caixia Zhu, Qing Hong, Kaiyuan Wang, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 10, pp. 109560-109560
Closed Access | Times Cited: 10
Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
Monique Patrício Singulani, Ana Flávia Fernandes Ferreira, Paulina Sepúlveda Figueroa, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102231-102231
Closed Access | Times Cited: 9
Focused ultrasound-mediated cerium-based nanoreactor against Parkinson's disease via ROS regulation and microglia polarization
Yifei Gao, Limin Zhai, Jiapeng Chen, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 580-594
Closed Access | Times Cited: 9

Scroll to top